PMC:7402624 / 12229-12489
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 396 | 118-126 | Species | denotes | patients | Tax:9606 |
| 400 | 109-117 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 401 | 155-157 | Disease | denotes | HD | MESH:D006816 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T91 | 109-117 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T92 | 138-140 | Disease | denotes | RD | http://purl.obolibrary.org/obo/MONDO_0009973 |
| T93 | 155-157 | Disease | denotes | HD | http://purl.obolibrary.org/obo/MONDO_0007739 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T144 | 138-140 | http://purl.obolibrary.org/obo/CLO_0008770 | denotes | RD |
| T145 | 163-165 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
| T146 | 249-251 | http://purl.obolibrary.org/obo/CLO_0008933 | denotes | S5 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T38 | 44-47 | Chemical | denotes | PCA | http://purl.obolibrary.org/obo/CHEBI_36751|http://purl.obolibrary.org/obo/CHEBI_62248 |
| T40 | 138-140 | Chemical | denotes | RD | http://purl.obolibrary.org/obo/CHEBI_73812 |
| T41 | 155-157 | Chemical | denotes | HD | http://purl.obolibrary.org/obo/CHEBI_73925 |
| T42 | 249-251 | Chemical | denotes | S5 | http://purl.obolibrary.org/obo/CHEBI_29386 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T82 | 0-260 | Sentence | denotes | We first used principal component analysis (PCA) to examine the general distribution of immune profiles from COVID-19 patients (n = 118), RD (n = 60), and HD (n = 36) using 193 immune parameters identified by high-dimensional flow cytometry (tables S5 and S6). |